Exploring gut microbiota and metabolite alterations in patients with thyroid-associated ophthalmopathy using high-throughput sequencing and untargeted metabolomics

• Published in: Frontiers in endocrinology (Lausanne) Vol. 15; p. 1413890
• Main Authors: Zhang, Xiran, Dong, Kui, Zhang, Xinxin, Kang, Zhiming, Sun, Bin
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 29-07-2024
• Subjects: Adult; Case-Control Studies; Endocrinology; Feces - microbiology; Female; Gastrointestinal Microbiome; Graves Ophthalmopathy - genetics; Graves Ophthalmopathy - metabolism; Graves Ophthalmopathy - microbiology; high throughput sequencing; High-Throughput Nucleotide Sequencing; Humans; intestinal flora; Male; metabolite alterations; Metabolome; Metabolomics - methods; Middle Aged; RNA, Ribosomal, 16S - genetics; thyroid-associated ophthalmopathy; untargeted metabolomics; untargeted metabolomics; thyroid-associated ophthalmopathy; high throughput sequencing; metabolite alterations; intestinal flora
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2024.1413890

Thyroid-associated ophthalmopathy (TAO) is an autoimmune-driven orbital inflammatory disease. Despite research efforts, its exact pathogenesis remains unclear. This study aimed to characterize the intestinal flora and metabolic changes in patients with TAO to identify the flora and metabolites associated with disease development.
Thirty patients with TAO and 29 healthy controls were included in the study. The intestinal flora and metabolites were analyzed using high-throughput sequencing of the 16S rRNA gene and non-targeted metabolomics technology, respectively. Fresh fecal samples were collected from both populations for analysis.
Reduced gut richness and diversity were observed in patients with TAO. Compared to healthy controls, significant differences in relative abundance were observed in patients with TAO at the order level
, family level
, genus level
,
,
,
,
,
,
, and
(logFC>1 and P<0.05).
and
were closely associated with clinical symptoms in patients with TAO. Among the 184 significantly different metabolites, 63 were upregulated, and 121 were downregulated in patients with TAO compared to healthy controls. The biosynthesis of unsaturated fatty acids was the significantly enriched metabolic pathway. Correlation analysis revealed
was positively correlated with NAGlySer 15:0/16:0, FAHFA 3:0/20:0, and Lignoceric Acid, while
was positively correlated with Cer 18:0;2O/16:0; (3OH) and ST 24:1;O4/18:2.
Specific intestinal flora and metabolites are closely associated with TAO development. Further investigation into the functional associations between these flora and metabolites will enhance our understanding of TAO pathogenesis.